In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates

被引：12

|

作者：

Cormican, MG

Jones, RN

机构：

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1996年 / 37卷 / 04期

关键词：

D O I：

10.1093/jac/37.4.847

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：847 / 849

页数：3

相关论文

共 32 条

[1] In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates
Ling, TKW
Liu, EYM
Cheng, AFB
CHEMOTHERAPY, 1999, 45 (01) : 22 - 27
[2] Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species
Snydman, DR
McDermott, L
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 : S96 - S100
[3] Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci
Coque, TM
Singh, KV
Murray, BE
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1011 - 1016
[4] In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens
Crokaert, F
Aoun, M
Duchateau, V
Grenier, P
Vandermies, A
Klastersky, J
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 696 - 698
[5] In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219)
Barry, AL
Brown, SD
Fuchs, PC
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) : 324 - 327
[6] COMPARATIVE ANTIMICROBIAL ACTIVITY AND SPECTRUM OF CP-99,219, A NOVEL FLUOROQUINOLONE, TESTED AGAINST CIPROFLOXACIN-RESISTANT CLINICAL ISOLATES
MURPHY, SP
CORMICAN, MG
JONES, RN
IRISH JOURNAL OF MEDICAL SCIENCE, 1995, 164 (04) : 271 - 273
[7] In-vitro activity of fosfomycin against vancomycin-resistant enterococci
Allerberger, F
Klare, I
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 211 - 217
[8] In vitro activity of daptomycin against isolates of vancomycin-resistant enterococci
Praharaj, Ira
Sujatha, S.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 346 - 347
[9] IN-VITRO ACTIVITY OF A NEW FLUOROQUINOLONE, CP-99,219, AGAINST STRAINS OF NEISSERIA-GONORRHOEAE
KNAPP, JS
NEAL, SW
PAREKH, MC
RICE, RJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) : 987 - 989
[10] Activity of trovafloxacin (CP-99,219) against Legionella isolates: In vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pig with L pneumophila pneumonia
Edelstein, PH
Edelstein, MAC
Ren, JJ
Polzer, R
Gladue, RP
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) : 314 - 319

← 1 2 3 4 →